The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma

被引：0
|
作者：
Liang Peng
Jin-Qi Liu
Cheng Xu
Xiao-Dan Huang
Ling-Long Tang
Yu-Pei Chen
Ying Sun
Jun Ma
机构：
[1] Sun Yat-sen University Cancer Center,Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
来源：
Radiation Oncology | / 14卷
关键词：
Nasopharyngeal carcinoma; Interval; Induction chemotherapy; Radiotherapy; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis
    Qin, Haimei
    Wang, Rong
    Wei, Guijiang
    Wang, Huaifei
    Pan, Guogang
    Hu, Rentong
    Wei, Yesheng
    Tang, Renguang
    Wang, Junli
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2018, 275 (02) : 525 - 534
  • [22] Cognitive dysfunction in patients with nasopharyngeal carcinoma after induction chemotherapy
    Wang, Jun
    Lian, Chen-Lu
    Zheng, Hua
    Lin, Li-E
    Yu, Yi-Feng
    Lin, Qin
    Wu, San-Gang
    ORAL ONCOLOGY, 2020, 111
  • [23] Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study
    Zhang, Bin
    Hu, Ying
    Xiong, Rui-Hua
    Pan, Yu-Fei
    Xu, Qian-Lan
    Kong, Xiang-Yun
    Cai, Rui
    Chen, Qiu-Qiu
    Tang, Hua-Ying
    Jiang, Wei
    ONCOTARGET, 2017, 8 (08) : 14078 - 14088
  • [24] High expression of sphingosine kinase 1 is associated with poor prognosis in nasopharyngeal carcinoma
    Li, Wenhua
    Tian, Zhiqiang
    Qin, Hong
    Li, Ni
    Zhou, Xiaoqing
    Li, Jian
    Ni, Bing
    Ruan, Zhihua
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 460 (02) : 341 - 347
  • [25] Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy
    Pei-Yu Huang
    Ting-Ting Zeng
    Xiaojiao Ban
    Meng-Qing Li
    Bao-Zhu Zhang
    Ying-Hui Zhu
    Wen-Feng Hua
    Hai-Qiang Mai
    Li Zhang
    Xin-Yuan Guan
    Yan Li
    BMC Cancer, 16
  • [26] Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy
    Huang, Pei-Yu
    Zeng, Ting-Ting
    Ban, Xiaojiao
    Li, Meng-Qing
    Zhang, Bao-Zhu
    Zhu, Ying-Hui
    Hua, Wen-Feng
    Mai, Hai-Qiang
    Zhang, Li
    Guan, Xin-Yuan
    Li, Yan
    BMC CANCER, 2016, 16
  • [27] Radiotherapy alone and with concurrent chemotherapy for nasopharyngeal carcinoma: A retrospective study
    Katano, Atsuto
    Takahashi, Wataru
    Yamashita, Hideomi
    Yamamoto, Kentaro
    Ando, Mizuo
    Yoshida, Masafumi
    Saito, Yuki
    Abe, Osamu
    Nakagawa, Keiichi
    MEDICINE, 2018, 97 (18)
  • [28] Nasopharyngeal carcinoma:: Radiotherapy alone or in combination with chemotherapy?
    Grüner, A
    Grabenbauer, GG
    Rödel, C
    Weidenbecher, M
    Martus, P
    Iro, H
    Sauer, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (12) : 591 - 596
  • [29] Expression of cytoskeleton-associated protein 4 is associated with poor prognosis and metastasis in nasopharyngeal carcinoma
    Cai, Manbo
    Wu, Weijun
    Deng, Shengling
    Yang, Qiao
    Wu, Haibiao
    Wang, Haiyun
    Zhang, Jiaxing
    Feng, Qisheng
    Shao, Jianyong
    Zeng, Yixin
    Li, Jianjun
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 248 (12) : 1085 - 1094
  • [30] Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis
    He, Yan
    Zhao, Zhihao
    Wang, Ying
    Chai, Jiamin
    He, Jialing
    Wang, Jingjing
    He, Ling
    Guan, Hui
    Wei, Zhigong
    Liu, Zheran
    Mu, Xiaoli
    Peng, Xingchen
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (08): : 2067 - 2076
12345